BioCentury
ARTICLE | Finance

Newly launched Cure Ventures taking hands-on approach to company creation

Three co-founders with experience at other firms hope to seed about 20 companies with $350M first fund

April 4, 2023 11:41 AM UTC

A trio of VCs with experience at Third Rock, 5AM, Omega Funds, Polaris and other investment firms has launched Cure Ventures, a Boston-based firm that hopes to seed about 20 start-ups with its $350 million first fund.

Co-founder Richard Lim, one of the three managing partners at Cure, told BioCentury the team will consider platform deals, asset-focused investments and even white-space science as it deploys the fund...